Dengue and severe dengue with neurological complications: a challenge for prevention and control
2024

Dengue and Severe Dengue with Neurological Complications

Sample size: 16944 publication Evidence: moderate

Author Information

Author(s): Francelino Emanuelle de Oliveira, Puccioni-Sohler Marzia

Primary Institution: Universidade Federal do Estado do Rio de Janeiro

Hypothesis

What are the current methods to prevent dengue fever and its severe forms, particularly those with neurological complications?

Conclusion

Vaccines, vector control, and personal protection measures are essential for preventing dengue and its neurological complications.

Supporting Evidence

  • The CYD-TDV/Dengvaxia vaccine shows 72.7% efficacy against hospitalizations.
  • The TAK-003/DENVax vaccine shows 90.4% efficacy against hospitalizations.
  • The TV003/TV005 vaccine shows 79.6% efficacy for symptomatic dengue.

Takeaway

Dengue is a serious disease that can affect the brain, and we can help prevent it by using vaccines and protecting ourselves from mosquito bites.

Methodology

The study is a narrative review of current dengue prevention methods.

Limitations

The review may not cover all recent developments in dengue prevention.

Participant Demographics

Participants included individuals aged 18 to 59 years in Brazil.

Statistical Information

Confidence Interval

95%CI: 62.3–80.3%

Digital Object Identifier (DOI)

10.1055/s-00054595

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication